VIA
TNDM icon

Vident Investment Advisory’s Tandem Diabetes Care TNDM Stock Holding History

Vident Investment Advisory’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-5,000
Closed -$441K – 1115
2021
Q1 		$441K Hold
5,000
– – 0.01% 830
2020
Q4 		$478K Buy
+5,000
New +$515K 0.02% 733

Other funds holding TNDM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Vident Investment Advisory's TNDM Position: Q2 2021 in Review

Vident Investment Advisory sold out of Tandem Diabetes Care (TNDM) in Q2 2021, closing a stake of 5,000 shares — an estimated $441K sold.

Vident Investment Advisory first reported a position in TNDM in Q4 2020 and held it in 2 quarters. The position peaked at $478K in Q4 2020. 303 funds tracked by Wall St. Rank hold TNDM as of Q2 2021.

  • Vident Investment Advisory reported no remaining Tandem Diabetes Care position as of Q2 2021 after selling out during the quarter.
  • Vident Investment Advisory sold 5,000 Tandem Diabetes Care shares in Q2 2021, an estimated $441K.
  • Vident Investment Advisory first reported a position in Tandem Diabetes Care in Q4 2020 and held it in 2 quarters.
  • Vident Investment Advisory's Tandem Diabetes Care position peaked at $478K in Q4 2020.
  • 303 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2021.

Based on Vident Investment Advisory's 13F filing for Q2 2021, filed 13 Aug 2021.